ClinicalTrials.Veeva

Menu
R

Rajiv Gandhi Cancer Institute and Research Centre | Clinical Research (Dr D.C.Doval)

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Dacomitinib
Palbociclib
Lorlatinib
Durvalumab
Ravulizumab
LY3537982
Enzalutamide
Pembrolizumab
PF-07220060
Letrozole

Parent organization

This site is a part of Rajiv Gandhi Cancer Institute and Research Centre

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

12 of 24 total trials
Locations recently updated

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

The purpose of this study is to evaluate two study medicines (encorafenib plus cetuximab) taken alone or together with standard chemotherapy for the...

Active, not recruiting
Neoplasms
Drug: Cetuximab
Drug: Oxaliplatin

The purpose of this study is to assess if adding LY3537982 in combination with standard of care anti-cancer drugs is more effective than standard of...

Enrolling
Carcinoma, Non-Small-Cell Lung
Neoplasm Metastasis
Drug: Carboplatin
Drug: Pemetrexed

The purpose of this study is to evaluate the efficacy and safety of repotrectinib and crizotinib in participants with locally advanced or metastatic...

Enrolling
Carcinoma, Non-Small-Cell Lung
Drug: Crizotinib
Drug: Repotrectinib

The reason for this study is to see if the study drug, selpercatinib, compared to placebo is effective and safe in delaying cancer return in particip...

Enrolling
Carcinoma, Non-Small-Cell Lung
Drug: Placebo
Drug: Selpercatinib
Locations recently updated

This study is researching a clinical treatment combination with two experimental drugs called pozelimab and cemdisiran. The study is focused on patie...

Enrolling
Paroxysmal Nocturnal Hemoglobinuria
Drug: Pozelimab
Drug: Ravulizumab
Locations recently updated

The purpose of the study is to compare Mezigdomide (CC-92480/BMS-986348) with carfilzomib and dexamethasone (MeziKD) against carfilzomib and dexameth...

Enrolling
Relapsed or Refractory Multiple Myeloma
Drug: Mezigdomide
Drug: Dexamethasone

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer.

Active, not recruiting
Advanced Breast Cancer
Drug: ARV-471
Drug: Fulvestrant

The purpose of this study is to learn about the safety and how effective the study medicine (PF-07220060) plus fulvestrant is compared to the study d...

Enrolling
Advanced or Metastatic Breast Cancer
Drug: Everolimus
Drug: Fulvestrant

Researchers are looking for new ways to treat people with metastatic non-small cell lung cancer (NSCLC) that is PD-L1 positive.* Metastatic means can...

Active, not recruiting
Non-Small-Cell Lung Carcinoma
Lung Neoplasms
Biological: Pembrolizumab/Vibostolimab
Biological: Pembrolizumab

The purpose of this study is to evaluate the efficacy and safety of Zanidatamab plus CisGem (Cisplatin and Gemcitabine) with or without the addition...

Enrolling
Biliary Tract Cancer
HER2 Gene Mutation
Drug: Cisplatin
Drug: Gemcitabine

A study to learn about safety and find out maximum tolerable dose of palbociclib given in combination with chemotherapy (temozolomide with irinotecan...

Active, not recruiting
Neuroblastoma
Rhabdomyosarcoma
Drug: Cyclophosphamide
Drug: Temozolomide

The purpose of the study is to evaluate the safety and efficacy of talazoparib in combination with enzalutamide compared with placebo in combination...

Active, not recruiting
Prostate Cancer
Drug: Placebo plus enzalutamide
Drug: talazoparib plus enzalutamide

Trial sponsors

Pfizer logo
R
Boehringer Ingelheim logo
Bristol-Myers Squibb (BMS) logo
Lilly logo
Jazz Pharmaceuticals logo
Loxo Oncology logo
Merck Sharp & Dohme (MSD) logo
Regeneron Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems